INS and Alzheimer disease: Alterations in inflammatory/cellular stress pathways (mitogen‐activated protein kinases, MAPK), insulin signaling, and markers of energetic stress (5′ adenosine monophosphate – activated protein kinase, AMPK) have all been implicated in AD and the amyloidogenic pathway.